A Plea for Neutral Comparison Studies in Computational Sciences

od Boulesteix, Anne-Laure, Lauer, Sabine, Eugster, Manuel J. A.
Izdano 2013

Proteomic Analysis of Detergent Resistant Membrane Domains during Early Interaction of Macrophages with Rough and Smooth Brucella melitensis

od Lauer, Sabine A., Iyer, Srinivas, Sanchez, Timothy, Forst, Christian V., Bowden, Brent, Carlson, Kay, Sriranganathan, Nammalwar, Boyle, Stephen M.
Izdano 2014

Vacuolar uptake of host components, and a role for cholesterol and sphingomyelin in malarial infection

od Lauer, Sabine, VanWye, Jeffrey, Harrison, Travis, McManus, Heather, Samuel, Benjamin U., Hiller, N.Luisa, Mohandas, Narla, Haldar, Kasturi
Izdano 2000

Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial

od Ferreira, João Pedro, Verma, Subodh, Fitchett, David, Ofstad, Anne Pernille, Lauer, Sabine, Zwiener, Isabella, George, Jyothis, Wanner, Christoph, Zinman, Bernard, Inzucchi, Silvio E.
Izdano u Cardiovasc Diabetol (2020)

Adjuvant Subcutaneous Trastuzumab for HER2‐Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study

od Jung, Kyung Hae, Ataseven, Beyhan, Verrill, Mark, Pivot, Xavier, De Laurentiis, Michelino, Al‐Sakaff, Nedal, Lauer, Sabine, Shing, Mona, Gligorov, Joseph, Azim, Hamdy A.
Izdano u Oncologist (2018)

Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial

od Ferreira, João Pedro, Fitchett, David, Ofstad, Anne Pernille, Kraus, Bettina Johanna, Wanner, Christoph, Zwiener, Isabella, Zinman, Bernard, Lauer, Sabine, George, Jyothis T, Rossignol, Patrick, Zannad, Faiez
Izdano u Am J Hypertens (2020)

Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial

od Ferreira, João Pedro, Kraus, Bettina Johanna, Zwiener, Isabella, Lauer, Sabine, Zinman, Bernard, Fitchett, David H., Koitka‐Weber, Audrey, George, Jyothis T., Ofstad, Anne Pernille, Wanner, Christoph, Zannad, Faiez
Izdano u J Am Heart Assoc (2021)

11 years’ follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

od Cameron, David, Piccart-Gebhart, Martine J, Gelber, Richard D, Procter, Marion, Goldhirsch, Aron, de Azambuja, Evandro, Castro, Gilberto, Untch, Michael, Smith, Ian, Gianni, Luca, Baselga, Jose, Al-Sakaff, Nedal, Lauer, Sabine, McFadden, Eleanor, Leyland-Jones, Brian, Bell, Richard, Dowsett, Mitch, Jackisch, Christian
Izdano u Lancet (2017)